Targeted therapies show initial effectiveness in subset of papillary thyroid cancer
COLUMBUS, Ohio - Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for...
NEWS INDEX
AACR pubs 1st set of screening recs from childhood cancer predisposition workshop
PHILADELPHIA -- The American Association for Cancer Research (AACR) has published its first set of consensus screening recommendations for children with common cancer predisposition syndromes...
Attacking metastatic tumors in the brain
(Bethesda, MD, June 05, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported...
Trends in reoperation after initial lumpectomy for breast cancer
Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative...
Generous health insurance plans encourage overtreatment, but may not improve health
CATONSVILLE, MD, June 5, 2017 - Offering comprehensive health insurance plans with low deductibles and co-pay in exchange for higher annual premiums seems like a...
Research suggests possible new treatment for EGFR-positive lung cancer
ASCO Perspective "It's been nearly 15 years since EGFR-targeted therapies were introduced, helping extend survival for thousands of patients in the time since. The second...
CAR T-Cell therapy sends multiple myeloma into lasting remission
ASCO Perspective "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission," said ASCO Expert...
Alectinib halts lung cancer growth more than a year longer than crizotinib
ASCO Perspective "The fact that this second-generation targeted treatment halted advanced lung cancer growth for more than two years while preventing brain metastases is a...
Adding a second HER2 blocker may lower chance of invasive breast cancer for some women
ASCO Perspective "The introduction and success of HER2 targeted treatment was a turning point in breast cancer care. It's promising that some women in this...
Early research suggests first immunotherapy for mesothelioma on the horizon
ASCO Perspective "We're seeing a second wave of immunotherapy with expansion of its use in more cancer types. This study shows that immunotherapy may represent...
Psychological intervention relieves distress in patients with advanced cancer
ASCO Perspective "A diagnosis of advanced cancer weighs heavily on patients and families, and this study gives a new approach that can ease this burden....
Remote therapy program improves quality of life, lowers distress after cancer diagnosis
ASCO Perspective "When the doctor says cancer, it can bring on a wave of emotions, fear, and uncertainty. Cancer care and treatment must be paired...
Psychological intervention lowers survivors’ fear of cancer recurrence
ASCO Perspective "The number of people surviving cancer is higher than ever before, but many survivors fear that the cancer will return even long after...
A single radiation treatment sufficiently relieves spinal cord compression symptoms
ASCO Perspective "Spinal cord compression is a debilitating condition that many patients with advanced cancer experience. Until now, patients often had to spend multiple days...
Abiraterone delays metastatic prostate cancer growth by 18 months, extends survival
ASCO Perspective "For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,"...
